Agilent Technologies Inc. (NYSE:A) today announced that is has established in-country manufacturing for its SureSelect portfolio at its facility in Hangzhou, China.
Agilent is a leading provider of next-generation
Companion diagnostic can help guide treatment decisions in cases of NSCLC
Agilent Technologies Inc. (NYSE:A) today announced that the company's PD-L1 IHC 22C3 pharmDx assay is now labeled for expanded use in